Moderating effect of alexithymia between problem gambling and psychotic experiences in university students

Carregando...
Imagem de Miniatura
Citações na Scopus
0
Tipo de produção
article
Data de publicação
2024
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
FEKIH-ROMDHANE, Feten
GHRISSI, Farah
STAMBOULI, Manel
HAKIRI, Abir
CHEOUR, Majda
HALLIT, Souheil
Citação
BMC PSYCHIATRY, v.24, n.1, article ID 19, 9p, 2024
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundMost of the young individuals with problem gambling (PG) or psychotic experiences (PEs) are less prone to seek medical help. Therefore, community-based studies investigating the relationship between these entities in non-clinical young people across a continuum of severity are warranted. To this end, the present study proposes to advance knowledge on the mechanisms that potentially underlie the association between PG and PEs, by examining the role of a potential moderator, i.e. alexithymia, in this relationship.MethodsA total of 399 participants enrolled in this study (mean age = 21.58 +/- 3.20 years) participated in an online cross-sectional survey. The South Oaks Gambling Screen (SOGS), the Prodromal Questionnaire-Brief (PQ-B), and the Toronto alexithymia scale (TAS-20) were used.ResultsThirty-three (8.3%) participants had problem-gambling, whereas 13 (3.3%) were probable pathological gamblers. Moderation analysis results adjusted over confounders (age, household crowding index, marital status, personal history of mental disorder, other illegal drug use) showed that the interaction PG by alexithymia (p = .018) was significantly associated with PEs scores. At moderate (Beta = 1.93) and high (Beta = 3.38) levels of alexithymia, more PG was significantly associated with more PEs scores.ConclusionFindings suggest that GP may have a different impact on PEs depending on the individual's level of alexithymia. As such, both alexithymia and gambling behavior should be considered in the clinical assessment of young people who present with PEs, which can help in implementing more tailored and individualized treatment plans.
Palavras-chave
Gambling problem, Psychotic experiences, Alexithymia, Students, Moderation
Referências
  1. American Psychiatric Association (APA), 2013, Diagnostic and statistical manual of mental disorders: DSM-5, V5th, DOI 10.1176/appi.books.9780890425596
  2. Aragay N, 2012, COMPR PSYCHIAT, V53, P9, DOI 10.1016/j.comppsych.2011.02.004
  3. BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X
  4. Barberis N, 2023, J CHILD FAM STUD, V32, P2652, DOI 10.1007/s10826-022-02303-3
  5. Barberis N, 2023, PSYCHOL HEALTH MED, V28, P1251, DOI 10.1080/13548506.2022.2045331
  6. Bergamini A, 2018, J BEHAV ADDICT, V7, P348, DOI 10.1556/2006.7.2018.47
  7. Bonnaire C, 2010, ANN MED-PSYCHOL, V168, P350, DOI 10.1016/j.amp.2009.03.024
  8. Bonnaire C, 2017, AM J ADDICTION, V26, P152, DOI 10.1111/ajad.12506
  9. Borras L, 2007, AM J ADDICTION, V16, P269, DOI 10.1080/10550490701389765
  10. Braun B, 2014, J BEHAV ADDICT, V3, P189, DOI 10.1556/JBA.3.2014.3.7
  11. Brewer R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150664
  12. Calado F, 2016, J BEHAV ADDICT, V5, P592, DOI 10.1556/2006.5.2016.073
  13. Calado F, 2017, J GAMBL STUD, V33, P397, DOI 10.1007/s10899-016-9627-5
  14. Cassetta BD, 2018, SCHIZOPHR RES, V192, P463, DOI 10.1016/j.schres.2017.04.006
  15. Compton MT, 2005, PSYCHIAT RES, V135, P35, DOI 10.1016/j.psychres.2005.03.004
  16. Corbeil O, 2021, CNS DRUGS, V35, P461, DOI 10.1007/s40263-021-00801-4
  17. Desai RA, 2009, J CLIN PSYCHIAT, V70, P1250, DOI [10.4088/JCP.08m04359, 10.4088/JCP.m04359]
  18. DeVylder JE, 2014, PSYCHOL MED, V44, P3503, DOI 10.1017/S0033291714000944
  19. DeVylder JE, 2017, SCHIZOPHRENIA BULL, V43, P993, DOI 10.1093/schbul/sbx038
  20. DeVylder JE, 2014, PSYCHIAT SERV, V65, P774, DOI 10.1176/appi.ps.201300254
  21. Di Luzio M., 2022, Schizophrenia Bull Open, V3, pgac068, DOI [10.1093/schizbullopen/sgac068, DOI 10.1093/SCHIZBULLOPEN/SGAC068]
  22. Dowling NA, 2016, ADDICT BEHAV, V58, P21, DOI 10.1016/j.addbeh.2016.02.012
  23. Dowling NA, 2015, AUST NZ J PSYCHIAT, V49, P519, DOI 10.1177/0004867415575774
  24. El Frenn Y, 2022, BMC PSYCHOL, V10, DOI 10.1186/s40359-022-00719-6
  25. Ered A, 2017, EUR PSYCHIAT, V43, P9, DOI 10.1016/j.eurpsy.2017.01.327
  26. Fekih-Romdhane F, 2023, INT J MENT HEALTH AD, DOI 10.1007/s11469-023-01048-4
  27. Gaweda L, 2018, SCHIZOPHR RES, V192, P317, DOI 10.1016/j.schres.2017.05.042
  28. González-Roz A, 2017, J GAMBL STUD, V33, P371, DOI 10.1007/s10899-016-9652-4
  29. Granero R, 2021, J PSYCHIATR RES, V136, P374, DOI 10.1016/j.jpsychires.2021.02.025
  30. Haddad P, 2022, BMC PSYCHOL, V10, DOI 10.1186/s40359-022-00727-6
  31. Hall LM, 2023, SCHIZOPHR RES, V262, P104, DOI 10.1016/j.schres.2023.10.029
  32. Haydock M, 2015, COMPR PSYCHIAT, V58, P122, DOI 10.1016/j.comppsych.2015.01.003
  33. Hayes A. F., 2022, Introduction to mediation, moderation, and conditional process analysis: a regression-based approach, V3rd, DOI 10.1111/JEDM.12050
  34. Hodgins DC, 2015, INT J MENT HEALTH AD, V13, P699, DOI 10.1007/s11469-015-9572-z
  35. Hodgins DC, 2011, LANCET, V378, P1874, DOI 10.1016/S0140-6736(10)62185-X
  36. Jacob L, 2018, SCHIZOPHR RES, V201, P79, DOI 10.1016/j.schres.2018.05.026
  37. Jauregui P, 2017, J GAMBL STUD, V33, P1081, DOI 10.1007/s10899-017-9675-5
  38. Kandri TA, 2014, PSYCHIAT RES, V220, P348, DOI 10.1016/j.psychres.2014.07.066
  39. Kim HS, 2018, REV BRAS PSIQUIATR, V40, P441, DOI 10.1590/1516-4446-2017-2307
  40. Kim HS, 2018, CAN J PSYCHIAT, V63, P370, DOI 10.1177/0706743717730825
  41. LESIEUR HR, 1987, AM J PSYCHIAT, V144, P1184
  42. Lincoln TM, 2017, EUR PSYCHIAT, V42, P111, DOI 10.1016/j.eurpsy.2016.12.010
  43. Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626
  44. Loewy RL, 2011, SCHIZOPHR RES, V129, P42, DOI 10.1016/j.schres.2011.03.029
  45. Loewy RL, 2005, SCHIZOPHR RES, V79, P117, DOI 10.1016/j.schres.2005.03.007
  46. Luminet O, 2018, Alexithymia: Advances in research, theory, and clinical practice
  47. LUMLEY MA, 1995, PSYCHOTHER PSYCHOSOM, V63, P201, DOI 10.1159/000288960
  48. Macía L, 2023, COMPR PSYCHIAT, V122, DOI 10.1016/j.comppsych.2023.152364
  49. Marchetti D, 2019, BRAIN SCI, V9, DOI 10.3390/brainsci9080191
  50. Melki IS, 2004, J EPIDEMIOL COMMUN H, V58, P476, DOI 10.1136/jech.2003.012690
  51. Moreno C, 2013, WORLD PSYCHIATRY, V12, P251, DOI 10.1002/wps.20070
  52. Nanda P, 2016, SCHIZOPHR RES, V170, P80, DOI 10.1016/j.schres.2015.11.030
  53. Newbury JB, 2023, SCHIZOPHRENIA BULL, V49, P1042, DOI 10.1093/schbul/sbad017
  54. Norman H, 2019, EVID-BASED MENT HEAL, V22, P36, DOI 10.1136/ebmental-2018-300029
  55. O'Driscoll C, 2014, CLIN PSYCHOL REV, V34, P482, DOI 10.1016/j.cpr.2014.07.002
  56. Oh H, 2022, SCHIZOPHR RES, V248, P198, DOI 10.1016/j.schres.2022.09.004
  57. Parker JDA, 2005, PSYCHOTHER PSYCHOSOM, V74, P51, DOI 10.1159/000082027
  58. Peritogiannis V, 2020, J NEUROSCI RURAL PRA, V11, P333, DOI 10.1055/s-0040-1709262
  59. Petry NM, 2017, PSYCHOL ADDICT BEHAV, V31, P951, DOI 10.1037/adb0000290
  60. Picardi A, 2012, PSYCHOPATHOLOGY, V45, P159, DOI 10.1159/000330261
  61. Pozza A, 2017, Bollettino di Psicologia Applicata, V65
  62. Saha S, 2011, SCHIZOPHR RES, V127, P246, DOI 10.1016/j.schres.2010.12.012
  63. Salles BM, 2023, COGN BEHAV THERAPY, V52, P110, DOI 10.1080/16506073.2022.2117734
  64. Savnikova A, 2021, EUR PSYCHIAT, V64, pS494, DOI 10.1192/j.eurpsy.2021.1322
  65. Secades-Villa R, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01931
  66. Secades-Villa R, 2014, ADICCIONES, V26, P247, DOI 10.20882/adicciones.6
  67. Sharman S, 2019, ADDICT BEHAV, V97, P20, DOI 10.1016/j.addbeh.2019.05.013
  68. Solmi M, 2022, MOL PSYCHIATR, V27, P281, DOI 10.1038/s41380-021-01161-7
  69. Sundqvist K, 2019, J GAMBL STUD, V35, P757, DOI 10.1007/s10899-019-09851-2
  70. Taylor G.J., 1999, Disorders of affect regulation: alexithymia in medical and psychiatric illness
  71. Taylor GJ, 2013, J AM PSYCHOANAL ASS, V61, P99, DOI 10.1177/0003065112474066
  72. Toneatto T, 2009, J ADDICT DIS, V28, P193, DOI 10.1080/10550880903014775
  73. Toplak ME, 2007, J BEHAV DECIS MAKING, V20, P103, DOI 10.1002/bdm.544
  74. van der Velde J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124803
  75. van Rijn S, 2011, PSYCHIAT RES, V187, P100, DOI 10.1016/j.psychres.2010.10.007
  76. van 't Wout M, 2007, COMPR PSYCHIAT, V48, P27, DOI 10.1016/j.comppsych.2006.07.003
  77. Volberg Rachel A, 2010, Int J Adolesc Med Health, V22, P3
  78. Werbeloff N, 2012, ARCH GEN PSYCHIAT, V69, P467, DOI 10.1001/archgenpsychiatry.2011.1580
  79. Williams AD, 2012, BRIT J CLIN PSYCHOL, V51, P223, DOI 10.1111/j.2044-8260.2011.02022.x
  80. Xian H, 2008, PSYCHIAT RES, V160, P300, DOI 10.1016/j.psychres.2007.08.007
  81. Yakovenko I, 2018, INT GAMBL STUD, V18, P143, DOI 10.1080/14459795.2017.1364400
  82. Yakovenko I, 2016, SCHIZOPHR RES, V171, P50, DOI 10.1016/j.schres.2015.12.008
  83. Yau YHC, 2015, HARVARD REV PSYCHIAT, V23, P134, DOI 10.1097/HRP.0000000000000051
  84. Yi Y, 2023, EUR ARCH PSY CLIN N, V273, P679, DOI 10.1007/s00406-022-01492-8